These data indicate that MSCs-IT inhibit the recruitment of monocytes by reducing CCL2 production from fibroblasts and macrophages, thus affecting the pathogenesis of BLM-induced SSc (Fig. 6). This evidence concerns the gene CCL2 and systemic sclerosis.